Due to high demand, this product is limited to 20 per organization.
Genomic RNA isolated from a preparation of Severe acute respiratory syndrome-related coronavirus 2 strain 2019-nCoV/Hong Kong/VM20001061/2020.
Note: The SARS-Related Coronavirus 2, isolate Hong Kong/VM20001061/2020, passage 6 sequence shows 7 sequence variants (6 with single nucleotide polymorphisms and one 27-base pair deletion in the ORF6 region) compared to the SARS-Related Coronavirus 2, isolate Hong Kong/VM20001061/2020 (GISAID: EPI_ISL_412028). The variations were detected by whole genome sequencing. The sequence is available on the ATCC Genome Portal.
Genomic RNA from SARS-CoV-2 must be handled at BSL-2 containment.
Innocuity testing was performed on the extracted RNA and results reported on the Certificate of Analysis.
Acknowledgment for publications should read "The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: Genomic RNA from SARS-Related Coronavirus 2, Isolate Hong Kong/VM20001061/2020, NR-52388."